Effects of 20,000 EU of Clinical Center Reference Endotoxin (CCRE) Versus Placebo(ENDOHEART)
Clinical trial NCT03623022 · COMPLETED
Trial details
- NCT number
- NCT03623022
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2019-09-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.